Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;171(6):1379-91.
doi: 10.1111/bph.12411.

Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS

Affiliations
Review

Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS

N Murataeva et al. Br J Pharmacol. 2014 Mar.

Abstract

The endogenous cannabinoid signalling system, composed of endogenous cannabinoids, cannabinoid receptors and the enzymes that synthesize and degrade the endogenous cannabinoids, is much more complex than initially conceptualized. 2-Arachidonoylglycerol (2-AG) is the most abundant endocannabinoid and plays a major role in CNS development and synaptic plasticity. Over the past decade, many key players in 2-AG synthesis and degradation have been identified and characterized. Most 2-AG is synthesized from membrane phospholipids via sequential activation of a phospholipase Cβ and a diacylglycerol lipase, although other pathways may contribute in specialized settings. 2-AG breakdown is more complicated with at least eight different enzymes participating. These enzymes can either degrade 2-AG into its components, arachidonic acid and glycerol, or transform 2-AG into highly bioactive signal molecules. The implications of the precise temporal and spatial control of the expression and function of these pleiotropic metabolizing enzymes have only recently come to be appreciated. In this review, we will focus on the primary organization of the synthetic and degradative pathways of 2-AG and then discuss more recent findings and their implications, with an eye towards the biological and therapeutic implications of manipulating 2-AG synthesis and metabolism.

Linked articles: This article is part of a themed section on Cannabinoids 2013. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-6.

Keywords: 2-AG; arachidonic acid; cannabinoid; diacylglycerol; hydrolysis; metabolism; monoacylglycerol lipase; synaptic plasticity; synthesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
2-AG trafficking and its action at the synapse. (A) 2-AG synthesis and breakdown. Schematic representation of an excitatory terminal and post-synaptic spine. Conventional action potential-induced neurotransmitter release (e.g. glutamate) occurs via activation of calcium channels adjacent to transmitter-filled vesicles, which fuse with the membrane to release their contents. 2-AG can be produced either following synaptic depolarization (e.g. DSE) or by activation of Gq/11-coupled GPCRs, such as group I mGlu receptors, which then activate PLCβ (PLCβ, cleaving phosphatidyl bisphosphate (PIP2) into DAG and inositol trisphosphate (IP3). DAG is hydrolysed by DAG lipase, yielding 2-AG. Rather than being released from vesicles, lipophilic endocannabinoids cross the membrane, perhaps utilizing facilitated transport. The mechanism of subsequent passage across the synapse is unknown but may involve carrier proteins. Activation of pre-synaptic CB1 receptors inhibits transmitter release by inhibiting Ca2+ channels. On the post-synaptic side, 2-AG can be broken down into glycerol and AA by the enzyme ABHD6, embedded in the membrane. On the pre-synaptic side, 2-AG can be broken down by MAGL, loosely associated with the plasma membrane, or, in principle, by ABHD12, a transmembrane protein, into glycerol and AA. (B) ABHD12 localization on Golgi. Emerging evidence suggests that ABHD12 is embedded in the Golgi membrane, with its active site facing the lumen.
Figure 2
Figure 2
Primary routes of 2-AG synthesis and degradation. 2-AG synthesis can potentially occur from three precursors: (1) DAG (via DAGL), in turn, DAG can be synthesized from PIP2 via PL C-β (PLCβ); (2) 2-Arachidonoyl-LPA via 2-LPA phosphatase (MAG kinase reverses the actions of 2-LPA phosphatase); and (3) 2-Arachidonoyl-LPI via a lyso-PLC, 2-Arachidonoyl-LPI can, in turn, be synthesized from PI via the actions of PLA1 (PIP2 phosphatases produce PI from PIP2). 2-AG metabolism can potentially occur via five different routes: (1) MAGL, FAAH, ABHD6 and ABHD12 hydrolyse 2-AG into AA and glycerol; (2) COX-2 converts 2-AG into PGE2-G; (3) MAG kinase converts 2-AG into 2-arachidonoyl-LPA (2-LPA phosphatase reverses the actions of MAG kinase); (4) cytochrome p450 converts 2-AG into 11,12-EET and (5) 12-lipoxygenase (12-LOX) can oxygenate 2-AG into 12-HETE-G.

References

    1. Ahn K, McKinney MK, Cravatt BF. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev. 2008;108:1687–1707. - PMC - PubMed
    1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ CGTP Collaborators. The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol. 2013;170:1449–1867. - PMC - PubMed
    1. Alger BE, Kim J. Supply and demand for endocannabinoids. Trends Neurosci. 2011;34:304–315. - PMC - PubMed
    1. Atwood BK, Straiker A, Mackie K. CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons. Neuropharmacology. 2012;63:514–523. - PMC - PubMed
    1. Bauer M, Chicca A, Tamborrini M, Eisen D, Lerner R, Lutz B, et al. Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem. 2012;287:36944–36967. - PMC - PubMed

Publication types